SILVER CLINICS UK TOPCO LIMITED
Get an alert when SILVER CLINICS UK TOPCO LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-03-31
Overdue
Confirmation statement due
2026-05-29 (this month)
Last made up 2025-05-15
Watchouts
Cash
£521K
Latest balance sheet
Net assets
£3M
Equity attributable
Employees
181
Average over period
Profit before tax
-£21M
Period ending 2024-03-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Annual accounts overdue
Due 2026-03-31.
Net assets
1-year trend · vs Industrials median
Accounts
1-year trend · latest reflected 2024-03-31
| Metric | Trend | 2024-03-31 |
|---|---|---|
| Turnover | £18,761,215 | |
| Operating profit | -£19,944,119 | |
| Profit before tax | -£20,840,840 | |
| Net profit | -£20,545,500 | |
| Cash | £521,064 | |
| Total assets less current liabilities | £14,609,833 | |
| Net assets | £2,986,411 | |
| Equity | £2,986,411 | |
| Average employees | 181 | |
| Wages | £3,685,767 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 |
|---|---|---|
| Operating margin | -106.3% | |
| Net margin | -109.5% | |
| Return on capital employed | -136.5% | |
| Current ratio | 0.37x | |
| Interest cover | -22.08x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have considered the financial performance of the group through to March 2026. Future revenues have been prudently forecast and the quarterly covenant tests through to March 2026 as calculated will be passed under the financial forecast. Separately, the liquidity of the group was forecast through to March 2026 and the group is forecast to have sufficient liquidity to fund trading obligations. The forecast was further sensitised and a 10% reduction in forecast sales resulted in a forecast breach of the financial covenants and a liquidity shortfall during the period to March 2026. The majority investor has provided the directors with a letter of support that confirms their intention and ability to provide financial support as needed to ensure compliance with banking covenants and to maintain sufficient liquidity. The directors are satisfied with the letter of support provided by the majority investor to financially support the group, and they are comfortable with this level of potential equity injection. The directors are satisfied with the ability and intention of the majority investor to provide this support if required. After making enquiries and taking account of the factors noted above, the directors have a reasonable expectation that the group and company has adequate resources to continue in operational existence for foreseeable future. The Board has assessed and concluded that the Group is expected to continue as a going concern for a period of 12 months from the date of signing these Financial Statements. In reaching this conclusion, the directors have received letters of support from its majority investor and have satisfied themselves that their investor has the intention and the ability to provide support for a period of at least 12 months from the date of approval of the financial statements, if required. Accordingly, the group and company continues to adopt the going concern basis in preparing the financial statements.”
Group structure
- SILVER CLINICS UK TOPCO LIMITED · parent
- Silver Clinics UK Bidco Limited 100%
- The Private Clinic Group Limited 100%
- TPC Group Limited 100%
- Tracie Giles Limited 100%
- River Aesthetics Group Limited 100%
- River Aesthetics Limited 100%
Significant events
- “On 3 April 2024, the group acquired the entire issued share capital of Vitalise Limited for £425,000.”
- “On 4 February 2025, the group signed an Amendment and Restatement Agreement to the existing bank facility. There were no changes to the term, margin or security. A capital repayment holiday was granted for the three quarters ending June 2025 as part of the amendment agreement the bank agreed to waive all historic covenant breaches.”
- “On 16 October 2024, 650 £1 Ordinary B shares of the parent company were allotted. On the same date, the Ordinary shares of the parent company were redesignated as A Ordinary shares.”
- “On each of 31 October 2024 and 20 December 2024, £1,000,000 A Ordinary shares were allotted.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BINELLO, Alessandro | Director | 2023-05-16 | Nov 1970 | Italian |
| RICCIOTTI, Walter | Director | 2023-05-16 | Jan 1971 | Italian |
| RONI, Francesca | Director | 2023-05-16 | May 1981 | Italian |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Walter Ricciotti | Individual | Significant influence | 2023-05-16 | Active |
| Alessandro Binello | Individual | Significant influence | 2023-05-16 | Active |
Filing timeline
Last 20 of 34 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-02-07 RESOLUTIONS Resolution
- 2024-11-03 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-12-18 | SH01 | capital | Capital allotment shares | |
| 2025-11-20 | SH01 | capital | Capital allotment shares | |
| 2025-09-11 | SH01 | capital | Capital allotment shares | |
| 2025-09-10 | SH01 | capital | Capital allotment shares | |
| 2025-09-10 | SH01 | capital | Capital allotment shares | |
| 2025-07-30 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2025-07-22 | SH01 | capital | Capital allotment shares | |
| 2025-05-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-05-22 | SH01 | capital | Capital allotment shares | |
| 2025-05-22 | SH01 | capital | Capital allotment shares | |
| 2025-05-22 | SH01 | capital | Capital allotment shares | |
| 2025-03-26 | AAMD | accounts | Accounts amended with accounts type group | |
| 2025-03-26 | AAMD | accounts | Accounts amended with accounts type group | |
| 2025-03-14 | AAMD | accounts | Accounts amended with accounts type group | |
| 2025-02-26 | AA | accounts | Accounts with accounts type group | |
| 2025-02-07 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-06 | SH01 | capital | Capital allotment shares | |
| 2025-02-06 | SH01 | capital | Capital allotment shares | |
| 2024-11-03 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 12
- Capital events
- 11
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one